Website coming soon

Due to our imminent relocation to the North East of England
and the expansion of Glythera's operational capabilities
we are currently re-developing this site and apologise for any inconvenience caused.

Please contact us at info@glythera.com with any enquires

We're Recruiting!

Please click on the position of interest for full information:

Our Technology

PermaLink™

For the selective and stable functionalisation of protein and peptide based therapeutics. More >

PermaCarb™

Maximise the in vivo benefits of your glycosylated therapeutics with a range of degredation resistant glycan analogues More >